Provided by Tiger Trade Technology Pte. Ltd.

Cellebrite

11.05
-0.2600-2.30%
Post-market: 11.150.1000+0.90%19:30 EDT
Volume:3.81M
Turnover:42.76M
Market Cap:2.77B
PE:48.12
High:11.40
Open:11.30
Low:11.01
Close:11.31
52wk High:19.98
52wk Low:9.58
Shares:250.79M
Float Shares:124.51M
Volume Ratio:0.56
T/O Rate:3.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.2296
EPS(LYR):0.3100
ROE:12.42%
ROA:3.92%
PB:5.15
PE(LYR):35.65

Loading ...

Cellebrite to host AI technology talk highlighting new Genesis agentic AI platform for investigations

Reuters
·
Jun 05

Cellebrite Announces Upcoming Investor Events on June 10, 2026

THOMSON REUTERS
·
Jun 05

VisionWave names Einav Eliraz CFO of Israeli unit

Reuters
·
Jun 03

Is It Time To Reassess Cellebrite DI (CLBT) After The Recent Share Price Rebound?

Simply Wall St.
·
May 31

Cellebrite management to meet virtually with Lake Street

TIPRANKS
·
May 30

A Look At Cellebrite DI (NasdaqGS:CLBT) Valuation As AI And FedRAMP Cloud Momentum Build

Simply Wall St.
·
May 29

Cellebrite DI (CLBT) Gets a Buy from TD Cowen

TIPRANKS
·
May 28

Cellebrite DI Initiated at Buy by DA Davidson

Dow Jones
·
May 27

Cellebrite DI Ltd : D.a. Davidson Initiates Coverage With Buy Rating; Price Target $20

THOMSON REUTERS
·
May 27

Cellebrite initiated with a Buy at DA Davidson

TIPRANKS
·
May 27

Cellebrite CMO David Nicholas Gee disposes of $74,265 in common shares

Reuters
·
May 27

Cellebrite participates in a conference call with Needham

TIPRANKS
·
May 22

Three Companies Priced Below Estimated Value In May 2026

Simply Wall St.
·
May 19

Cellebrite publishes transcript of Q1 2026 earnings call

Reuters
·
May 16

Cellebrite price target lowered to $15 from $18 at Needham

TIPRANKS
·
May 15

Cellebrite DI Is Maintained at Buy by Needham

Dow Jones
·
May 15

Exploring US High Growth Tech Stocks This May 2026

Simply Wall St.
·
May 15

Needham Remains a Buy on Cellebrite DI (CLBT)

TIPRANKS
·
May 15

Cellebrite DI Ltd : Needham Cuts Target Price to $15 From $18

THOMSON REUTERS
·
May 15

Jonathan Ho Reiterates Buy on Cellebrite, Citing Strong Beat, Expanding Margins and AI-Driven Growth with 20%+ Upside Potential

TIPRANKS
·
May 15